- 2015
- Press releases - 12.11.2015
Inserm goes into space with Thomas Pesquet
In one year’s time, French ESA astronaut Thomas Pesquet will take off for the International Space Station (ISS), on board which he will conduct scientific experiments prepared by researchers from Inserm. The scientific and technical programme for this ESA (European Space Agency) mission includes significant participation by France, managed by CNES (National Centre for Space Studies). Research projects from 3 Inserm laboratories will be conducted in orbit. Their purpose will be to study the effects of space on bone density, blood pressure and sleep. Data collected before, during and after the 6-month mission will be analysed by the researchers back on earth to obtain a better understanding of the related pathologies.
- Press releases - 11.11.2015
An indicator for predicting emergence from coma
Researchers from Unit 825, “Brain imaging and neurological handicaps” show that the quality of communication between two structures in the brain predicts patient recovery at 3 months.
- Press releases - 10.11.2015
November 14th 2015: world diabetes day
Initiated by the International Diabetes Federation and the World Health Organization, World Diabetes Day, which takes place next Saturday, 14 November, is aimed at sensitising and informing the general public about diabetes prevention and management. Diabetes, type 1 or type 2, is a chronic disease characterised by insufficient production of insulin, or by poor […]
- What's on? - 10.11.2015
November 14th 2015: world diabetes day
Initiated by the International Diabetes Federation and the World Health Organization, World Diabetes Day, which takes place next Saturday, 14 November, is aimed at sensitising and informing the general public about diabetes prevention and management. Diabetes, type 1 or type 2, is a chronic disease characterised by insufficient production of insulin, or by poor […]
- Press releases - 09.11.2015
Fatty acids, essential for the nervous system… of the gut (as well)
Two Inserm research teams have just shown that failure of the intestine to produce a lipid “messenger” is associated with Crohn’s disease, a common and highly disabling inflammatory bowel disease (IBD).
- Press releases - 06.11.2015
THE INTESTINAL FLORA AS A COMPLEMENT TO IMMUNOTHERAPY IN ONCOLOGY
The vital role of the intestinal flora in successful immunotherapy has just been revealed in a study published in the journal Science. Intestinal bacteria have been identified that can improve the therapeutic response to this drug and reduce a side-effect, “inflammatory colitis,” regularly encountered with this treatment.
This research implies that the efficacy of immunotherapy in oncology might in future be dictated by the composition of the patient’s intestinal flora. The researchers hope to develop a test for predicting the response to these treatments by analysing the intestinal flora. They also hope to offer those patients who need it the opportunity to reconstitute a flora which will restore the anti-tumour effect of the immunotherapy.
- Press releases - 06.11.2015
Inserm at COP21
L’Inserm s’engage dans le cadre de la COP21 : symposiums scientifiques, conférences pour le grand public.
- Press releases - 03.11.2015
An anti-diabetic drug corrects dyspraxia associated with neonatal diabetes
Researchers from Inserm and physicians from the Department of Paediatric Endocrinology, Gynaecology and Diabetology at Necker Hospital for Sick Children (AP-HP, Inserm U1016, Paris Descartes University, Imagine Institute) have developed an improved treatment for a rare form of early childhood diabetes associated with cognitive disorders. Their work, conducted in collaboration with the Neurophysiology Department of Pitié-Salpêtrière Hospital, AP-HP, shows that a drug used for decades to treat type 2 diabetes in older subjects acts on the brain of these children. It reduces their hyperactivity and improves their ability to perform precise movements such as writing. The work has recently been the subject of a publication in the journal Diabetes Care.
- Press releases - 29.10.2015
October 29th 2015: World Stroke Day
A Cerebrovascular Accident results from the interruption of blood flow to the brain. The deprivation of oxygen and essential nutrients causes brain cells to die, leading to permanent damage (speech or writing difficulty, memory problems, bodily paralysis to a greater or lesser extent), or even sudden death.
- What's on? - 29.10.2015
October 29th 2015: World Stroke Day
A Cerebrovascular Accident results from the interruption of blood flow to the brain. The deprivation of oxygen and essential nutrients causes brain cells to die, leading to permanent damage (speech or writing difficulty, memory problems, bodily paralysis to a greater or lesser extent), or even sudden death. World Cerebrovascular Accident Day is organised on 29 […]